Maripau Wealth Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Maripau Wealth Management's LLY Position: Q1 2026 in Review
Maripau Wealth Management reduced its Eli Lilly (LLY) stake by 6.8% in Q1 2026, selling an estimated $30.4K and leaving 411 shares worth $378K. The position accounts for 0.17% of the portfolio, ranked #106.
Maripau Wealth Management first reported a position in LLY in Q2 2025 and has held it in 4 quarters since. The position peaked at $474K in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Maripau Wealth Management held 411 shares of Eli Lilly worth $378K as of Q1 2026.
- Maripau Wealth Management sold 30 Eli Lilly shares in Q1 2026, an estimated $30.4K.
- Eli Lilly made up 0.17% of Maripau Wealth Management's portfolio in Q1 2026, its #106 holding.
- Maripau Wealth Management first reported a position in Eli Lilly in Q2 2025 and has held it in 4 quarters since.
- Maripau Wealth Management's Eli Lilly position peaked at $474K in Q4 2025.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Maripau Wealth Management's 13F filing for Q1 2026, filed 15 May 2026.